Companies / Evozyne
Evozyne
Chicago, United States
Evozyne designs novel therapeutic proteins with generative AI to solve immunology’s toughest challenges.
Evozyne, based in Chicago, United States, has 2 investors on file, among them IQT and Valor Equity Partners. Its site was last checked 20 Nov 2026: site answers.
SEC Form D filings
3 filingsFiled by Evozyne, Inc. with the SEC. A Form D reports a private offering; it is not a priced round.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from IQT
192 companies on its checked portfolioIts portfolio leans to AI & Machine Learning (26%), Semiconductors & Electronics (18%), Space & Defense (16%).
More from Valor Equity Partners
198 companies on its checked portfolioIts portfolio leans to AI & Machine Learning (17%), Enterprise Software (13%), Healthcare & Biotech (11%).
See Valor Equity Partners' full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Evozyne and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when IQT adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/evozyne.com/investors
# also
GET /v1/companies/evozyne.com
GET /v1/companies/evozyne.com/news